Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients

Journal of the American Society of Nephrology

Volumn 12, Issue 7, 2001, Pages 1508-1515

  Zoccali, C ^a   Mallamaci, F ^a   Benedetto, F A ^a   Tripepi, G ^a   Parlongo, S ^a   Cataliotti, A ^a   Cutrupi, S ^a   Giacone, G ^a   Bellanuova, I ^a   Cottini, E ^a   Malatino, L S ^a  

^a Divisione di Nefrologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0034918556     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials
2. Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure
3. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure
4. Effect of ultra-filtration on plasma concentrations of atrial natriuretic peptide in hemodialysis patients
5. Plasma alpha-human atrial natriuretic peptide and volume status in chronic hemodialysis patients
6. Plasma natriuretic peptides and cardiac volume during acute changes in intra-vascular volume in hemodialysis patients
7. Changes in atrial natriuretic peptide and plasma renin activity following changes in right atrial pressure in patients with chronic renal failure
8. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients
9. Role of volume overload in dialysis-refractory hypertension
10. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure
11. Assessment of postdialysis dry weight: A comparison of techniques
12. Plasma level of atrial natriuretic peptide as an indicator of increased cardiac load in uremic patients
13. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis
14. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor
15. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
16. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension
17. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension
18. Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population
19. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
20. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
21. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
22. The prognostic importance of left ventricular geometry in uremic cardiomyopathy
23. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease
24. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults
25. Ageing induces left ventricular remodelling in normotensive subjects
26. Mathematic modelling of dialysis therapy
27. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients
28. Pathophysiology of left ventricular hypertrophy in dialysis patients
29. Outcome and risk factors for left ventricular disorders in chronic uremia
30. Brain natriuretic peptide in an elderly population
31. The natural history of myocardial disease in dialysis patients
32. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
33. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?
34. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations